Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas.

Kimby E, Östenstad B, Brown P, Hagberg H, Erlanson M, Holte H, Linden O, Johansson AS, Ahlgren T, Wader K, Wahlin BE, Delabie J, Sundström C; Nordic Lymphoma Group (NLG).

Leuk Lymphoma. 2015;56(9):2598-607. doi: 10.3109/10428194.2015.1014363. Epub 2015 Mar 11.

PMID:
25686644
2.

Continuous lenalidomide treatment for newly diagnosed multiple myeloma.

Palumbo A, Hajek R, Delforge M, Kropff M, Petrucci MT, Catalano J, Gisslinger H, Wiktor-Jędrzejczak W, Zodelava M, Weisel K, Cascavilla N, Iosava G, Cavo M, Kloczko J, Bladé J, Beksac M, Spicka I, Plesner T, Radke J, Langer C, Ben Yehuda D, Corso A, Herbein L, Yu Z, Mei J, Jacques C, Dimopoulos MA; MM-015 Investigators.

N Engl J Med. 2012 May 10;366(19):1759-69. doi: 10.1056/NEJMoa1112704. Erratum in: N Engl J Med. 2012 Jul 19;367(3):285.

3.

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

Juliusson G, Karlsson K, Lazarevic VLj, Wahlin A, Brune M, Antunovic P, Derolf A, Hägglund H, Karbach H, Lehmann S, Möllgård L, Stockelberg D, Hallböök H, Höglund M; Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group.

Cancer. 2011 Sep 15;117(18):4238-46. doi: 10.1002/cncr.26033. Epub 2011 Mar 8.

4.

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M.

Eur J Haematol. 2009 Aug;83(2):99-107. doi: 10.1111/j.1600-0609.2009.01256.x. Epub 2009 Apr 6.

PMID:
19385987
5.

B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome.

Lundin C, Heldrup J, Ahlgren T, Olofsson T, Johansson B.

Eur J Haematol. 2009 Jan;82(1):46-53. doi: 10.1111/j.1600-0609.2008.01166.x. Epub 2008 Nov 10.

PMID:
19067745
6.

Plastic deformation of single nanometer-sized crystals.

Sun L, Krasheninnikov AV, Ahlgren T, Nordlund K, Banhart F.

Phys Rev Lett. 2008 Oct 10;101(15):156101. Epub 2008 Oct 7.

PMID:
18999616
7.

An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients.

Nahi H, Hägglund H, Ahlgren T, Bernell P, Hardling M, Karlsson K, Lazarevic VLj, Linderholm M, Smedmyr B, Aström M, Hallböök H.

Haematologica. 2008 Nov;93(11):1734-8. doi: 10.3324/haematol.13227. Epub 2008 Aug 25.

8.

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

Olsson-Strömberg U, Simonsson B, Ahlgren T, Björkholm M, Carlsson K, Gahrton G, Hast R, Löfvenberg E, Linder O, Ljungman P, Malm C, Paul C, Rödjer S, Turesson I, Udén AM, Wahlin A, Killander A, Wadman B, Westin J, Vikrot O, Zettervall O, Oberg G; Swedish CML Study Group.

Hematol J. 2004;5(6):462-6.

PMID:
15570285
9.

Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.

Storlazzi CT, Fioretos T, Paulsson K, Strömbeck B, Lassen C, Ahlgren T, Juliusson G, Mitelman F, Rocchi M, Johansson B.

Hum Mol Genet. 2004 Jul 15;13(14):1479-85. Epub 2004 May 26.

PMID:
15163636
10.

More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.

Höglund M, Brune M, Sallerfors B, Ahlgren T, Billström R, Hedenus M, Markevärn B, Nilsson B, Simonsson B, Stockelberg D, Wahlin A.

Bone Marrow Transplant. 2003 Dec;32(12):1119-24.

PMID:
14647265
11.

Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures.

Albin M, Björk J, Welinder H, Tinnerberg H, Mauritzson N, Billström R, Strömberg U, Mikoczy Z, Johansson B, Ahlgren T, Nilsson PG, Mitelman F, Hagmar L.

Scand J Work Environ Health. 2003 Oct;29(5):378-87.

12.

Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.

Barbouti A, Ahlgren T, Johansson B, Höglund M, Lassen C, Turesson I, Mitelman F, Fioretos T.

Br J Haematol. 2003 Jul;122(1):85-93.

PMID:
12823349
13.

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.

Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Löfvenberg E, Oberg G, Porwit-MacDonald A, Rådlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F; Scandinavian MDS Group.

Br J Haematol. 2003 Mar;120(6):1037-46.

PMID:
12648074
14.
15.

Acute myeloid leukemia with inv(16)(p13q22): involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign.

Billström R, Ahlgren T, Békássy AN, Malm C, Olofsson T, Höglund M, Mitelman F, Johansson B.

Am J Hematol. 2002 Sep;71(1):15-9. Review.

16.

High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.

Hallböök H, Simonsson B, Ahlgren T, Björkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Löfvenberg E, Malm C, Nilsson PG, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome AM, Vilen L, Wahlin A, Winquist I, Smedmyr B.

Br J Haematol. 2002 Sep;118(3):748-54.

PMID:
12181041
17.

Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia?

Björk J, Albin M, Welinder H, Tinnerberg H, Mauritzson N, Kauppinen T, Strömberg U, Johansson B, Billström R, Mikoczy Z, Ahlgren T, Nilsson PG, Mitelman F, Hagmar L.

Occup Environ Med. 2001 Nov;58(11):722-7.

18.

The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex.

Mauritzson N, Johansson B, Rylander L, Albin M, Strömberg U, Billström R, Ahlgren T, Mikoczy Z, Mitelman F, Hagmar L, Nilsson PG.

Br J Haematol. 2001 May;113(2):347-56.

PMID:
11380398
19.

Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents.

Albin M, Björk J, Welinder H, Tinnerberg H, Mauritzson N, Johansson B, Billström R, Strömberg U, Mikoczy Z, Ahlgren T, Nilsson PG, Mitelman F, Hagmar L.

Scand J Work Environ Health. 2000 Dec;26(6):482-91.

20.

[No more screws in malunited femoral neck fractures. "Total hip alloplasty prevents reoperations and suffering"].

Ahlgren T.

Lakartidningen. 2000 Nov 15;97(46):5287-8. Swedish. No abstract available.

PMID:
11116866

Supplemental Content

Loading ...
Support Center